Form 4 · ABBV
AbbVie director Susan E. Quaggin reports an award of 59 stock Equivalent units
Susan E. Quaggin, an AbbVie director, filed a Form 4 on Oct 2, 2026 at 5:00 PM ET reporting transactions on Sep 30, 2026.
The filing reports 59 stock Equivalent units in a grant or award (code A).
Reporting person
- Susan E. Quaggin, director (as filed: Quaggin Susan E)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | A | Stock Equivalent Units (derivative) | 59 | $261.59 | Acquired | 918 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 2, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
AbbVie company file → · More AbbVie filings
Disclosures
- Editor holdings in ABBV
- The editor holds no position in AbbVie (ABBV). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.